RNA Analysis Market Size to Reach US$ 30.48 Bn by 2030

According to Vision Research Reports, the RNA analysis market is expected to garner growth at a CAGR of 14.44% during forecast period 2021 to 2030 and to reach around US$ 30.48 billion by 2030.

Growth Factors

Technological advancements in this market can be attributed to the increasing applications of transcriptome sequencing into life science for capturing polyadenylated RNA.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Collaborations between research institutes for the use of transcriptomics in various applications would drive market growth.

Full Report is Ready | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39075

 

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global RNA analysis market due to increasing prevalence and incidence of cancer and infectious diseases in this region. In 2019, North America hold a major market share for RNA analysis and this trend will remain in the forecast period as well. According to the American Cancer Society, about 1.9 million cases were found in United States suffering from Cancer and 608,570 deaths were notified in the year 2021. The American Cancer Society also states that a 2021 special section was arranged to focus more on population suffering from COVID-19 and cancer together and overall American healthcare system. Moreover, increase in such activities and presence of favorable healthcare infrastructure is fueling the growth of the overall regional market to a large extent. ​

 

The market in the region is boosted by rising demand for various assay technologies, quantification of multiplexed RNA, increased need for genetic testing and personalized treatment, and an increase in genetic variety and genetic mutation occurrences. Because of the vast number of biotech companies with well-established infrastructure and cutting-edge technical platforms, North America is the most prominent region. Other factors driving market expansion include expanding opportunities, rising healthcare expenditures, and the implementation of government programs. The commercial sector's continued investment in transcriptomics-related research and development is allowing regional market players to produce tailored medicines. The market in the region is growing due to advancements in sequencing technology, increased acceptance of NGS technology, and an increase in the number of partnerships and collaborations. The presence of important players, the expansion of the healthcare sector, and the presence of new transcriptomics and RNA analysis kits and products in the region by key companies are projected to propel the market in the region forward.

Report Coverage

Report Scope	Details
Market Size	US$ 30.48 billion by 2030
Growth Rate	CAGR of 14.44% From 2021 to 2030
Largest Market	North America
Base Year	2021
Forecast Period	2021 to 2030
Segments Covered	Technology, Product, Application, End-use
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned	Agilent Technologies; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.;QIAGEN; Thermo Fisher Scientific, Inc; Eurofins Scientific; Merck KGaA; Pacific Bioscience of California, Inc; Affymetrix, Inc; Danaher Corporation; Promega

 

The Reagents/Consumables Segment is Expected to Hold a Major Market Share in the RNA Analysis Market

The demand for detection and diagnosis is predicted to rise during the COVID epidemic, boosting the segment's growth. During the forecast period, the increased prevalence of infectious diseases and oncological occurrences are also expected to boost segmental growth. The demand for high-quality reagents is growing, as is the usage of medium and reagents in transcriptome investigations. The pharmaceutical industry's increased R&D efforts, government spending in life science research, and the growing research being done with integrated omics studies are all contributing to the consumables market.

According to American Cancer Society, In 2020, the treatment and diagnosis of cancer was reduce and distrubed by the COVID-19 pandemic. For instance, lockdown restricted access to care and in delaed in diagnosis and treatment which is expected to slow down the detection and diagnosis of cancer incidence but the advanced stage infectious disease increased mortality. According to World Health Organization-WHO, Cancer is one of the main reason of death worldwide, about 10 million deaths were noted in 2020, which was 1 in 6 deaths. According to World Health Organization-WHO 2020, Cancer-causing infections, such as human papillomavirus (HPV) and hepatitis, are responsible for approximately 30% of cancer cases in low- and lower-middle-income countries. Thus, the increasing prevalance of cancer and infectious diseases such as COVID-19 demanded high diagnostic rate in medical specialities and diagnostic care centers and thus expected to propel the segmental growth during the forecast period.

The growing prevalence of chronic diseases, rising number of hospital admissions due to infectious diseases, increasing healthcare expenditures are the factors supporting and expected to accelerte the growth and demand for Regents / Consumables and drive the market growth. COVID -19 has accelerated the consumption of the regents/consumables in various end users such as hospitals and diagnostic centers. The growing penetration of consumables also propel the grwoth of the segment in the market.

By Technology Analysis

Based on technology, real-time-PCR (qPCR) technology dominated the market with the largest revenue share of more than 56% in 2020 due to increased use of PCR for COVID-19 diagnostic across the globe. 

The technology is considered to be highly sensitive and quantitative and one of the most suitable methods for interrogating a comparatively small number of transcripts in a broad set of samples. PCR offers relatively high-sensitivity detection of SARS-CoV-2, evaluation of viral RNA in various types of clinical samples, detecting SARS-CoV-2 mutations, and evaluation of anti-SARS-CoV-2 drugs.

The sequencing segment is anticipated to witness substantial growth over the forecast years owing to advancements in the next-generation and SMRT sequencing technology. The presence of several companies providing single-cell RNA sequencing services and the advent of bioinformatics algorithms are also driving the growth of this market.

Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39075

By Product Analysis

Based on products, the kits & reagents segment accounted for the largest revenue share of over 58% in2020. Rising requirements for high-quality reagents and kits coupled with repeated use of reagents and media in transcriptome studies drive the segment growth. 

Growing R&D activities in the pharmaceutical sector and increasing government investments in life science research are the major factors expected to fuel this market for consumables.NGS roots have begun with the adaptation of some SMART cDNA synthesis technology mainly for RNA-sequencing applications. 

By Application Analysis

The Infectious diseases and pathogenesis segment accounted for a substantial market share of more than 20% in 2020 and is closely followed by alternative RNA splicing applications. Identification of susceptible cells is crucial for understanding the pathogenic mechanism. 

The RNA structure and molecular dynamics segment is expected to expand at a significant CAGR from 2021 to 2028 as pharmaceutical importance for RNA in the development of a new drug is gradually growing.

By End-use Analysis

The government institutes & academic centers segment reported the highest revenue share of over 32% in 2020. The rising adoption of high throughput technologies for the effective process of RNA analysis by government institutes and academic centersis driving the segment growth.

Research in drug discovery is also contributing to the market that is followed by clinical diagnostics. For instance, in April 2021, researchers developed TORNADO-seq, an RNA sequencing-based drug discovery platform to monitor the expression of the large gene for a detailed study of cellular phenotypes in organoids.

The Italian Institute of Technology has signed a partnership agreement with European Molecular Biology Laboratory to expand their collaboration in research. This collaboration is anticipated to strengthen their database and share resources for the study. 

By Regional Analysis

North America accounted for the maximum revenue share of more than 46% in 2020. The growth is attributed to the rapid development of structure-based drug designs, increasing focus on transcriptomics research, and high investment in biopharmaceutical research and development. 

Growing investments by governments &enterprises are accelerating biotechnology research in Asia Pacific countries. The Japanese government and non-government organizations are highly supportive of the growth of biotechnology research in the country and provide funds to research in the fields of medicine and life sciences. 
 

Increasing focus on Asia Pacific countries is owing to the low-cost manufacturing services, is expected to provide growth opportunities for the manufacturers.

Key Players 

• Agilent Technologies, Inc.
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Eurofins Scientific
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Pacific Bioscience of California, Inc.
• Affymetrix, Inc.
• Danaher Corporation
• Promega

Market Segmentation

• By Technology 
  • Real Time-PCR (qPCR) Technology
  • Microarray Technology
  • Sequencing Technology
  • Others
• By Product 
  • Instruments
  • Kits & Reagents
    • miRNA & siRNA
    • Reverse Transcriptases& RT-PCR
    • RNA Extraction & Purification
    • RNA Interference
    • Others
  • Services
• By Application 
  • Construction of RNA Expression Atlas
  • Epigenetics
  • Infectious Diseases and Pathogenesis
  • Alternative RNA Splicing
  • RNA Structure & Molecular Dynamics
  • Development & Delivery of RNA Therapeutics
  • Others
• By End-use 
  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals & Clinics
• Regional
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Click Here to View Full Report Table of Contents

Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39075

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333